{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:03:04Z","timestamp":1787065384721,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.schres.2021.07.011","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T07:14:02Z","timestamp":1626765242000},"page":"12-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism"],"prefix":"10.1016","volume":"235","author":[{"given":"Ying","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi Wu","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiao","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Retnakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desheng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2021.07.011_bb0005","author":"Anon"},{"key":"10.1016\/j.schres.2021.07.011_bb0010","author":"Anon"},{"key":"10.1016\/j.schres.2021.07.011_bb0015","author":"Anon"},{"issue":"6","key":"10.1016\/j.schres.2021.07.011_bb0020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/WNF.0b013e31823429a7","article-title":"Thyroid adverse effects of psychotropic drugs: a review","volume":"34","author":"Bou Khalil","year":"2011","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.schres.2021.07.011_bb0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/YIC.0b013e328333ac1b","article-title":"Efficacy of valproate versus lithium in mania or mixed mania: a randomized, open 12-week trial","volume":"25","author":"Bowden","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.schres.2021.07.011_bb0030","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/sj.npp.1300023","article-title":"Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia","volume":"28","author":"Casey","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2021.07.011_bb0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pediatrneurol.2007.07.003","article-title":"Evolution of subclinical hypothyroidism in children treated with antiepileptic drugs","volume":"37","author":"Castro-Gago","year":"2007","journal-title":"Pediatr. Neurol."},{"issue":"10101","key":"10.1016\/j.schres.2021.07.011_bb0040","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.schres.2021.07.011_bb0045","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/wps.20204","article-title":"Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder","volume":"14","author":"Correll","year":"2015","journal-title":"World Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2021.07.011_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1176\/appi.ajp.2011.11040631","article-title":"Abnormal thyroid function tests in psychiatric patients: a red herring?","volume":"169","author":"Dickerman","year":"2012","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2021.07.011_bb0055","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1528-1157.1999.tb01595.x","article-title":"Long-term treatment of children with epilepsy with valproate or carbamazepine may cause subclinical hypothyroidism","volume":"40","author":"Eir\u00eds-Pu\u00f1al","year":"1999","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.schres.2021.07.011_bb0060","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S2215-0366(19)30132-4","article-title":"The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness","volume":"6","author":"Firth","year":"2019","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2021.07.011_bb0065","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1399-5618.2010.00814.x","article-title":"Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: a nested, matched case-control study","volume":"12","author":"Gau","year":"2010","journal-title":"Bipolar Disord."},{"issue":"1","key":"10.1016\/j.schres.2021.07.011_bb0070","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40345-016-0068-y","article-title":"Lithium side effects and toxicity: prevalence and management strategies","volume":"4","author":"Gitlin","year":"2016","journal-title":"Int. J. Bipolar Disord."},{"issue":"3","key":"10.1016\/j.schres.2021.07.011_bb0075","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s13760-018-0908-x","article-title":"The effect of antiepileptic drugs on thyroid hormonal function: valproic acid and phenobarbital","volume":"120","author":"G\u00fcng\u00f6r","year":"2020","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.schres.2021.07.011_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1586\/17512433.2015.1091302","article-title":"The effect of antiepileptic drugs on thyroid hormonal function: causes and implications","volume":"8","author":"Hamed","year":"2015","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.schres.2021.07.011_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002058","article-title":"Adverse renal, endocrine, hepatic, and metabolic events during maintenance mood stabilizer treatment for bipolar disorder: a population-based cohort study","volume":"13","author":"Hayes","year":"2016","journal-title":"PLoS Med."},{"issue":"5","key":"10.1016\/j.schres.2021.07.011_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2215-0366(15)00115-7","article-title":"Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses","volume":"2","author":"Henderson","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2021.07.011_bb0095","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.npp.1300273","article-title":"Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia","volume":"28","author":"Isaac","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.schres.2021.07.011_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1528-1157.1992.tb02297.x","article-title":"Thyroid function with antiepileptic drugs","volume":"33","author":"Isoj\u00e4rvi","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.schres.2021.07.011_bb0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1192\/bjp.175.4.336","article-title":"Lithium-associated clinical hypothyroidism. prevalence and risk factors","volume":"175","author":"Johnston","year":"1999","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"3","key":"10.1016\/j.schres.2021.07.011_bb0110","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0032-1313913","article-title":"Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy","volume":"43","author":"Kim","year":"2012","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1016\/j.schres.2021.07.011_bb0115","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4088\/JCP.v60n0409","article-title":"Lithium-induced subclinical hypothyroidism: review of the literature and guidelines for treatment","volume":"60","author":"Kleiner","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2021.07.011_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/bdi.12391","article-title":"Hypothyroidism risk compared among nine common bipolar disorder therapies in a large US cohort","volume":"18","author":"Lambert","year":"2016","journal-title":"Bipolar Disord."},{"issue":"2","key":"10.1016\/j.schres.2021.07.011_bb0125","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jpeds.2007.02.046","article-title":"Risk factors for development of subclinical hypothyroidism during valproic acid therapy","volume":"151","author":"Mikati","year":"2007","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.schres.2021.07.011_bb0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"issue":"26","key":"10.1016\/j.schres.2021.07.011_bb0135","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","article-title":"Subclinical hypothyroidism","volume":"376","author":"Peeters","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.schres.2021.07.011_bb0140","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0883073811421985","article-title":"Evaluation of subclinical hypothyroidism in ambulatory children with controlled epilepsy on valproate monotherapy","volume":"27","author":"Sahu","year":"2012","journal-title":"J. Child Neurol."},{"issue":"12","key":"10.1016\/j.schres.2021.07.011_bb0145","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrendo.2016.100","article-title":"Subclinical hypothyroidism in childhood - current knowledge and open issues","volume":"12","author":"Salerno","year":"2016","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.schres.2021.07.011_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1089\/thy.2018.0311","article-title":"Pregnancy and perinatal outcome among hypothyroid mothers: a population-based cohort study","volume":"29","author":"Turunen","year":"2019","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.schres.2021.07.011_bb0155","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.seizure.2013.09.006","article-title":"The effect of antiepileptic drugs on thyroid function in children","volume":"23","author":"Yilmaz","year":"2014","journal-title":"Seizure"},{"key":"10.1016\/j.schres.2021.07.011_bb0160","series-title":"Chinese National Guidelines of Diagnosis and Treatment for Schizophrenia","author":"Zhao","year":"2015"},{"key":"10.1016\/j.schres.2021.07.011_bb0165","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Wang, N., Wen, S.W. Li, M., Yuan, Y., Retnakaran, R., Zhang, R., Zhai, D. 2021. Mirtazapine use may increase the risk of hypothyroxinemia in patients affected by major depressive disorder, https:\/\/doi.org\/10.22541\/au.161170044.48225769\/v1.","DOI":"10.22541\/au.161170044.48225769\/v1"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996421002644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:41:58Z","timestamp":1760298118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996421002644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":33,"alternative-id":["S0920996421002644"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2021.07.011","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between valproate treatment for acute phase schizophrenia and risk of new onset hypothyroidism","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2021.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}